Literature DB >> 17524864

Diabetes as the cause of end-stage renal disease affects the pattern of post kidney transplant rehospitalizations.

M Ramezani1, K Ghoddousi, M Hashemi, H-R Khoddami-Vishte, S Fatemi-Zadeh, S H Saadat, H Khedmat, M Naderi.   

Abstract

INTRODUCTION: Although there are reports that link diabetes-induced end-stage renal disease (ESRD) with several post renal transplantation complications and conditions, few studies have directly focused on this issue. This study compared the pattern of rehospitalizations after renal transplantation among diabetic versus nondiabetic ESRD patients, measuring causes, length of stay, outcomes and costs.
METHODS: We retrospectively reviewed 366 randomly selected rehospitalization records of kidney transplant recipients between 1994 and 2006, including 69 who underwent renal transplantation due to diabetic nephropathy and 297, due to nondiabetic ESRD. We compared the two groups with respect to demographic and clinical variables: donor source, readmission pattern, rehospitalization cause, time interval between transplantation and hospitalization (T-H time), length of hospital stay (LOS), and intensive care unit (ICU) admission, hospital charges, and inpatient outcomes of graft loss and mortality.
RESULTS: The diabetes group, compared with nondiabetic group, had a greater mean age (53 +/- SD vs. 39 +/- SD years), proportion of admissions due to infections (44.9% vs. 32%) or renal dysfunction (14.5% vs. 29.6%), mean hospital charges ($5056 vs. $3046), and hospital mortality (18% vs. 4.3%; P<.05). Diabetic patients were readmitted sooner after transplantation than nondiabetic patients (11 vs. 18 months; P<.05). There was no difference between the groups with regard to gender, donor source, LOS, ICU admission, and graft loss.
CONCLUSION: The etiology of ESRD should be considered for scheduling post renal transplantation follow-up. Renal transplant recipients with diabetes-induced ESRD need further attention in follow-up programs.

Entities:  

Mesh:

Year:  2007        PMID: 17524864     DOI: 10.1016/j.transproceed.2007.03.074

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  Pharmacokinetics of total and unbound prednisone and prednisolone in stable kidney transplant recipients with diabetes mellitus.

Authors:  Ileana A Ionita; Ken Ogasawara; Reginald Y Gohh; Fatemeh Akhlaghi
Journal:  Ther Drug Monit       Date:  2014-08       Impact factor: 3.681

2.  Inclusion of dynamic clinical data improves the predictive performance of a 30-day readmission risk model in kidney transplantation.

Authors:  David J Taber; Arun P Palanisamy; Titte R Srinivas; Mulugeta Gebregziabher; John Odeghe; Kenneth D Chavin; Leonard E Egede; Prabhakar K Baliga
Journal:  Transplantation       Date:  2015-02       Impact factor: 4.939

Review 3.  The effect of diabetes on hospital readmissions.

Authors:  Kathleen M Dungan
Journal:  J Diabetes Sci Technol       Date:  2012-09-01

4.  Early rehospitalization after kidney transplantation: assessing preventability and prognosis.

Authors:  M Harhay; E Lin; A Pai; M O Harhay; A Huverserian; A Mussell; P Abt; M Levine; R Bloom; J A Shea; A B Troxel; P P Reese
Journal:  Am J Transplant       Date:  2013-10-28       Impact factor: 8.086

5.  Role of glycemic control on hospital-related outcomes in patients with diabetes mellitus undergoing renal transplantation.

Authors:  Elizabeth M Lamos; Marniker A Wijesinha; Seba Ramhmdani; Laurence S Magder; Kristi D Silver
Journal:  Diabetes Metab Syndr Obes       Date:  2017-01-05       Impact factor: 3.168

6.  Determinants of Poor Glycemic Control in Patients with Kidney Transplants: A Single-Center Retrospective Cohort Study in Canada.

Authors:  Daniel Chan Chun Kong; Ayub Akbari; Janine Malcolm; Mary-Anne Doyle; Stephanie Hoar
Journal:  Can J Kidney Health Dis       Date:  2020-05-18

7.  Hyperglycemia after renal transplantation: frequency and risk factors.

Authors:  Nahid Khalili; Zohreh Rostami; Ebrahim Kalantar; Behzad Einollahi
Journal:  Nephrourol Mon       Date:  2013-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.